Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neuroblastoma 44Ganglioneuroblastoma 5Medulloblastoma 4Lung Neoplasms 4Leukemia, Myelomonocytic, Juvenile 4Glioblastoma 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Kidney Neoplasms 3Head and Neck Neoplasms 3Gliosarcoma 3Glioma 3Central Nervous System Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Squamous Cell Carcinoma of Head and Neck 2Rhabdoid Tumor 2Recurrence 2Prostatic Neoplasms 2Pinealoma 2Oligodendroglioma 2Neoplasms 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Isotretinoin 1Doxycycline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acneiform Eruptions × Isotretinoin × Clear all
NCT04864717 2021-09-08

Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI

Lady Davis Institute

Phase 4 Unknown
98 enrolled

Neoplasms, Second Primary, Acneiform Eruptions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡